Glucagon-like peptide-1 causes pancreatic duodenal homebox-1 protena translocation from the citoplasma to the ncleos of pancreatic beta-cells by a cyclic adenosina monophosphate PKA-dependen mechanism
Treatment of people with type 1 diabetes with semaglutide or tirzepatide relevant in the future
Patents describe self-assembling peptide systems and implantable devices designed for months-long semaglutide release [21, 10], aligning with clinical research on long-acting formulations [22]
Related lab tests: Hemoglobin A1C, Glucose, Comprehensive Metabolic Panel, Kidney Profile, Lipid Panel, Lipase, Amylase, Hepatic Function Panel with GGT, CBC, Ferritin, Iron and TIBC, Vitamin B12, Folate, and Vitamin D
Radioactive iodine (RAI) therapy